Skip to content
Biosion
  • About
    • Executive Team
    • Development Team
    • Advisory Board
    • Careers
  • Platform
    • H3 Antibody Technology
    • SynTracer™ Internalization Platform
    • FlexibodyTM Bispecific Platform
  • Pipeline
  • Partners
  • News
  • Contact
  • English
  • 中文
  • About
    • Executive Team
    • Development Team
    • Advisory Board
    • Careers
  • Platform
    • H3 Antibody Technology
    • SynTracer™ Internalization Platform
    • FlexibodyTM Bispecific Platform
  • Pipeline
  • Partners
  • News
  • Contact
  • English
  • 中文

Careers

Join Our Team and Grow With Us

At Biosion, we are innovators, leaders, and collaborators. We love what we do and who we work with. And at the heart of everything we do is an intense desire to innovate for cures and to improve quality of life.

Job opportunities

Pipeline

Biosion is committed to developing therapies that will have significant impact in treating immune and oncologic diseases.

Our best-in-class and first-in-class portfolio is designed to address significant unmet medical needs through the development of mono and bi-specific protein therapeutics, antibody drug conjugates and macrophage stimulating agents for patients worldwide.

A Diversified Portfolio with Global Velocity

Patient-centric focus is integral to Biosion’s R&D strategy

Portfolio of global competitiveness with meaningful differentiation

Pipeline Assets Entering Phase I in 2021 and 2022

Drag table right
PROGRAM (TARGET)
POTENTIAL INDICATION(S)
PRE-CLINICAL
IND
PHASE I
PARTNERS

BSI-045B

TSLP

Atopic Dermatitis, Asthma, COPD

BSI-038

CD40

Solid Tumors

BSI-060T

SIGLEC-15

Solid Tumors

BSI-050

SIRPa

Breast Cancer

Available for Partnering

BSI-001

HER2

Breast Cancer Gastric Cancer

Available for Partnering

CDX-585

PD-1/ILT4

Solid Tumors

Other Assets in Preclinical Pipeline

Drag table right
PROGRAM (TARGET)
POTENTIAL INDICATION(S)
PRE-CLINICAL
IND
PHASE I
PARTNERS

BSI-501

FIC BsAB

Auto-Immune

BSI-706

Claudin 18.2-ADC

Solid Tumors

Available for Partnering

BSI-04702

TROP2-ADC

Solid Tumors

Undisclosed

FIC BsAB

Solid Tumors

Available for Partnering

Committed to bring next generation innovative therapeutics to treat immune and oncologic diseases.

LinkedIn

CHINA

BIOSION, INC.

5th Floor, Building D
3-1 Zhongdan Unit
South Longshan Rd
Jiangbei New District
Nanjing, Jiangsu, China 210061
Tel: (86) 025-5829-1977

USA

BIOSION USA, INC.

1 Innovation Way, Suite 300
Newark, DE 19711
Tel: 1-302-998-5126

Australia

BIOSION AUSTRALIA PTY LTD.

58 Gipps Street
Collingwood, Victoria 3066
Tel: 1-302-998-5126

Website by Bartlett Interactive
Terms Privacy
© 2022. All rights reserved.
Close Bitnami banner
Bitnami